Company Filing History:
Years Active: 2000
Title: Tomaz W Glinka: Innovator in Antibiotic Development
Introduction
Tomaz W Glinka, based in Sunnyvale, CA, is an esteemed inventor recognized for his contributions to the field of pharmaceuticals. With a focus on antibiotic innovations, Glinka's work demonstrates his commitment to developing novel solutions to combat bacterial infections.
Latest Patents
Glinka holds a patent for his invention concerning Cephalosporin antibiotics. The described invention includes novel compounds that exhibit antibiotic activity against a wide spectrum of organisms, including those resistant to beta-lactam antibiotics. The innovation encompasses unique pharmacologically acceptable salts and novel intermediates, essential for synthesizing these compounds and methods for their production.
Career Highlights
Currently, Tomaz W Glinka works at Microcide Pharmaceuticals, Inc., where he contributes to the research and development of groundbreaking antibiotic therapies. His expertise and innovative work play a vital role in addressing the challenges of antibiotic resistance.
Collaborations
Throughout his career, Glinka has collaborated with notable colleagues, including In-Seop Cho and Scott J Hecker. These partnerships enhance his research and development efforts, leading to more robust innovations in the pharmaceutical industry.
Conclusion
Tomaz W Glinka's work in antibiotic development showcases the importance of innovation in tackling global health challenges. His patent on Cephalosporin antibiotics reflects a significant advancement in pharmaceuticals, aimed at improving drug efficacy against resistant bacteria, ultimately benefiting public health.